@FiercePharma: Shift in law helps local pharma groups in the Philippines. FiercePharmaAsia story | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: WuXi clarifies just what AstraZeneca is buying, or actually what it isn't buying. Report | Follow @EricPFierce
@CarlyHFierce: Valeant's rep-retention plan worked. Now, its sales folks are 'ready and waiting.' FiercePharmaMarketing story | Follow @CarlyHFierce
> Leading PBM Express Scripts ($ESRX) expects 2016 adjusted earnings of $6.08-$6.28 per share, an increase of 10% to 14% from the company's reaffirmed guidance for 2015. Report
> India's government may exempt Sanofi's ($SNY) dengue vaccine, Dengvaxia, from large-scale clinical trials. Report
> Genmab has achieved a $3 million milestone payment in its DuoBody collaboration with Johnson & Johnson's ($JNJ) Janssen. More
> Sobi has received an orphan drug designation for hemophilia med Alprolix in Switzerland. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: UCLA spinout nabs $10M Series A to diagnose, track traumatic brain injury. Report | Follow @FierceMedDev
@EmilyWFierce: Hey doc, what's on the menu when pharma comes calling? Hint: It's not health food. Story from FiercePharmaMarketing | Follow @EmilyWFierce
> Micro-cap liquid biopsy Dx player Biocept nabs $15M financing from Chicago growth investor. Report
> Olympus played down early report of superbug infections linked to duodenoscope devices. Article
Biotech News
@FierceBiotech: As trouble mounts, a chastened Martin Shkreli says bad boy persona was just an 'experiment.' Article | Follow @FierceBiotech
@JohnCFierce: Orbimed rings up $950M for biotech Fund VI. Report | Follow @JohnCFierce
@DamianFierce: this is a particularly belabored headline. FDA release | Follow @DamianFierce
> Pfizer, Merck KGaA launch two more PhIII trials for avelumab. Item
> Baxalta and Momenta target AbbVie's blockbuster with positive biosim data. Article
> With Big Pharma backing, eFFECTOR plots solid tumor trial with $40M round. Report
> pSivida shares soar as eye drug/device passes its first PhIII test. Story
Pharma Manufacturing News
> Sun said to be discussing $2.3B deal for Intas: DealStreetAsia. Item
> GSK recalls nearly 130,000 Ventolin inhalers. More
> Alnylam looks at building $100M plant outside Cambridge. Story
> Novartis selling French Alcon plant to Recipharm. Article
> Sun says the FDA has issued warning letter for Halol plant. Report
Drug Delivery News
> Antibiotic gel can prevent infection in bone implants. Report
> Eli Lilly partners with Halozyme to develop subcutaneous injectables. News
> FDA approves first chewable extended-release tablet, creating new drug delivery partnership opportunity. More
> J&J's Janssen teams up with Intrexon for diabetes pill. Story
> Startup gets $7M in funding to test its toenail fungus-fighting micro-insert. Article
Pharma Asia News
> Shift in law helps local pharma groups in the Philippines. Item
> Sun Pharma said to be in talks to buy Intas for $2.3B. Story
> 2015 was the year of the (most likely Chinese) health hacker: FT. More
> SciClone Pharmaceuticals sets mucositis treatment for China. Item
> Indian M&A deals top $1.5B in 2015 led by overseas acquisitions. Article
And Finally... The pharma industry will give £200 million to the U.K.'s NHS in early rebate payments to help it pay for meds. More